跳至主要内容
临床试验/NCT00217009
NCT00217009终止早期 1 期

A Randomized Controlled Trial of Narrowband Ultraviolet B vs Topical Psoralen Plus Ultraviolet A Photochemotherapy for Hand and Foot Dermatoses

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2005年3月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
终止
发起方
Mayo Clinic
入组人数
3
试验地点
2
主要终点
Number of treatments required to reach clearance

研究概览

简要总结

Hand and foot skin diseases, such as dermatitis and psoriasis, that do not respond to topical creams can be treated with ultraviolet light therapy. Topical psoralen plus ultraviolet A (PUVA) is commonly used to treat these conditions, but requires additional time for the hands and feet to soak in psoralens before the light treatment. Newer narrowband ultraviolet B (NBUVB) units have become available which allow for light treatment without soaking first. The purpose of this study is to determine if NBUVB is as effective as PUVA for hand and foot skin diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Bilateral hand or foot skin disease (dermatitis, psoriasis, etc.) with symmetric distribution and severity.

排除标准

  • Age <18 years Pregnancy Liver disease Kidney disease History of skin cancer Phototherapy or systemic therapy for the skin condition in the preceding 3 months

结局指标

主要结局

Number of treatments required to reach clearance

时间窗: Baseline to 15 months

次要结局

  • Change in symptom score (erythema, scaling/hyperkeratosis, papular/vesicular eruption, and fissures)(Baseline to 15 months)
  • Change in global score(Baseline to 15 months)
  • Number of patients reaching clearance(Baseline to 15 months)
  • Adverse effects(Baseline to 15 months)
  • Number of days in remission(Baseline to 15 months)

研究者

发起方
Mayo Clinic
申办方类型
Other

研究点 (2)

Loading locations...

相似试验